Soleno Therapeutics, Inc.
SLNO
$73.64
$0.380.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.98M | -76.62M | -21.85M | -21.40M | -11.30M |
| Total Depreciation and Amortization | 503.00K | 500.00K | 494.00K | 490.00K | 489.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.88M | 55.68M | 7.75M | 6.44M | 2.59M |
| Change in Net Operating Assets | 2.61M | 5.51M | -4.04M | 1.94M | 1.91M |
| Cash from Operations | -23.99M | -14.93M | -17.65M | -12.53M | -6.31M |
| Capital Expenditure | -8.00K | -191.00K | -8.00K | -11.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.45M | 4.23M | -120.91M | -115.23M | -- |
| Cash from Investing | 6.44M | 4.04M | -120.92M | -115.24M | -- |
| Total Debt Issued | 49.89M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.18M | 2.28M | 152.75M | 938.00K | 123.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.06M | 2.28M | 152.75M | 938.00K | 123.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.52M | -8.61M | 14.18M | -126.83M | 117.24M |